Cargando…
Modifications of the Triaminoaryl Metabophore of Flupirtine and Retigabine Aimed at Avoiding Quinone Diimine Formation
[Image: see text] The potassium channel opening drugs flupirtine and retigabine have been withdrawn from the market due to occasional drug-induced liver injury (DILI) and tissue discoloration, respectively. While the mechanism underlying DILI after prolonged flupirtine use is not entirely understood...
Autores principales: | Wurm, Konrad W., Bartz, Frieda-Marie, Schulig, Lukas, Bodtke, Anja, Bednarski, Patrick J., Link, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908504/ https://www.ncbi.nlm.nih.gov/pubmed/35284765 http://dx.doi.org/10.1021/acsomega.1c07103 |
Ejemplares similares
-
Carba Analogues of Flupirtine and Retigabine with Improved Oxidation Resistance and Reduced Risk of Quinoid Metabolite Formation
por: Wurm, Konrad W., et al.
Publicado: (2022) -
Flupirtine Analogues: Explorative Synthesis and Influence of Chemical Structure on K(V)7.2/K(V)7.3 Channel Opening Activity
por: Surur, Abdrrahman S., et al.
Publicado: (2019) -
The Effects of the KCNQ Openers Retigabine and Flupirtine on Myotonia in Mammalian Skeletal Muscle Induced by a Chloride Channel Blocker
por: Su, Tzu-Rong, et al.
Publicado: (2012) -
Flupirtine: Clinical pharmacology
por: Harish, S, et al.
Publicado: (2012) -
Clinical utility of adjunctive retigabine in partial onset seizures in adults
por: Rejdak, Konrad, et al.
Publicado: (2012)